A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

Simple item page
dc.contributor.authorHappi, Christian
dc.date.accessioned2025-07-18T10:24:57Z
dc.date.issued2022-09-26
dc.identifier.uri10.3389/fmed.2022.956123
dc.identifier.urihttps://repository.run.edu.ng/handle/123456789/5810
dc.publisherFrontiers in Medicine
dc.titleA randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
A randomized, open.pdf
Size:
265.38 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Biological Sciences